Zhenming Jin
Shanghai, 201210, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors.
Journal: Protein & cell
Published: April 07, 2022
Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 05, 2022
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.
Journal: Protein & cell
Published: November 20, 2020
The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2.
Journal: Biochemical and biophysical research communications
Published: October 18, 2020
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.
Journal: Nature structural & molecular biology
Published: April 08, 2020
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
Journal: Science (New York, N.Y.)
Published: March 18, 2020
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.
Journal: Nature
Published: February 09, 2020
OsMADS32 interacts with PI-like proteins and regulates rice flower development.
Journal: Journal of integrative plant biology
Published: April 29, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026